Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix<sup>®</sup> Tetra, a Seasonal Hemagglutinin-Based Vaccine

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix<sup>®</sup> Tetra, a Seasonal Hemagglutinin-Based Vaccine

<b>Background/Objectives</b>: The combination of a hemagglutinin antigen (HA)-based inactivated influenza vaccine (IIV; Fluarix<sup>®</sup> Tetra; GlaxoSmithKline) with a nucleoprotein (NP)-based vaccine, such as OVX836, should increase the efficacy of influenza vaccines sinc...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicola Groth, Jacques Bruhwyler, Jessika Tourneur, Emilie Piat, Philippe Moris, Alexandre Le Vert, Florence Nicolas
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
influenza
universal vaccine
Phase 2a
healthy participants
hemagglutinin
seasonal vaccine
Online Access:https://www.mdpi.com/2076-393X/13/6/558
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/6/558

Similar Items